J. Jefferson Smith - Jan 20, 2023 Form 4 Insider Report for PRECISION BIOSCIENCES INC (DTIL)

Role
Chief Research Officer
Signature
/s/ John Alexander Kelly, Attorney-in-fact for Jefferson J. Smith
Stock symbol
DTIL
Transactions as of
Jan 20, 2023
Transactions value $
$0
Form type
4
Date filed
1/24/2023, 03:30 PM
Previous filing
Sep 9, 2022
Next filing
Mar 7, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DTIL Restricted Stock Units Award $0 +225K $0.00 225K Jan 20, 2023 Common Stock 225K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.
F2 Award vests in three equal annual installments beginning on January 20, 2024, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.